Advertisement

Differences between novel and conventional surveillance paradigms of ventilator-associated pneumonia

Published:December 13, 2014DOI:https://doi.org/10.1016/j.ajic.2014.10.029

      Objective

      To investigate the concordance between novel and conventional surveillance paradigms for ventilator-associated pneumonia (VAP).

      Methods

      This study was conducted at a regional teaching hospital in southern Taiwan with 5 acute intensive care units. To assess the validity of novel ventilator-associated event (VAE) surveillance, we retrospectively applied the VAE algorithm to analyze all VAP cases that were identified using conventional definitions between April 2010 and February 2014. Patient outcomes, including ventilator days, hospital stay lengths, and in-hospital mortality were recorded.

      Results

      Among 165 episodes of conventional VAP, 55 (33.3%), 40 (24.2%), 20 (12.1%), and 2 (1.2%) episodes were classified as a ventilator-associated condition, an infection-related ventilator-associated complication, possible VAP, and probable VAP, respectively, according to the new VAE algorithm. Changes in positive end-expiratory pressure and inspired oxygen fraction levels during the development of VAP were significant higher among each VAE category than for conventional VAP (all P < .001). In-hospital mortality was significantly higher among patients with ventilator-associated condition than for patients with conventional VAP (P = .0185).

      Conclusions

      In our study population, novel VAE surveillance only detected one-third of conventional VAP cases. Thus, more studies are needed to further validate VAE surveillance compared with conventional VAP by using strong microbiologic criteria, particularly bronchoalveolar lavage with a protected specimen brush for diagnosing VAP.

      Key Word

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Safdat N.
        • Dezfulian C.
        • Collard H.R.
        • Sain S.
        Clinical and economic consequences of ventilator-associated pneumonia: a systemic review.
        Crit Care Med. 2005; 33: 2184-2193
        • Rello J.
        • Ollendorf D.A.
        • Oster G.
        • Vera-Llonch M.
        • Ellm L.
        • Redman R.
        • et al.
        • VAP Outcome Scientific Advisory Group
        Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.
        Chest. 2002; 122: 2115-2121
        • Melsen W.G.
        • Rovers M.M.
        • Bonten M.J.
        Ventilator-associated pneumonia and mortality: a systematic review of observational studies.
        Crit Care Med. 2009; 37: 2709-2718
        • Skrupky L.P.
        • McConnel K.
        • Dallas J.
        • Kollef M.H.
        A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria.
        Crit Care Med. 2012; 40: 281-284
        • Uckay I.
        • Ahmed Q.A.
        • Sax H.
        • Pittet D.
        Ventilator-associated pneumonia as a quality indicator for patient safety?.
        Clin Infect Dis. 2008; 46: 557-563
        • Micheti C.P.
        • Fakhr S.M.
        • Ferguson P.L.
        • Cook A.
        • Moore F.O.
        • Gross R.
        AAST Ventilator-Associated Pneumonia Investigators. Ventilator-associated pneumonia rates at major trauma centers compared with a national benchmark: a multi-institutional study of the AAST.
        J Trauma Acute Care Surg. 2012; 72: 1165-1173
        • Klompas M.
        Interobserver variability in ventilator-associated pneumonia surveillance.
        Am J Infect Control. 2010; 38: 237-239
        • Fabregas N.
        • Eig S.
        • Torres A.
        • El-Ebiasry M.
        • Ramirez J.
        • de La Bellacasa J.P.
        • et al.
        Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies.
        Thorax. 1999; 54: 867-873
        • Klompas M.
        Eight initiatives that misleading lower ventilator-associated pneumonia rates.
        Am J Infect Control. 2012; 40: 408-410
        • Centers for Disease Control and Prevention (CDC)
        Ventilator-Associated Event Protocol.
        CDC, Atlanta2013 (Available from:) (Accessed May 3, 2014)
        • Magill S.S.
        • Fridkin S.K.
        Improving surveillance definitions for ventilator-associated pneumonia in an era of public reporting and performance measurement.
        Clin Infect Dis. 2012; 54: 378-380
        • Klompas M.
        Complication of mechanical ventilation: the CDC's new surveillance paradigm.
        N Engl J Med. 2013; 368: 1472-1475
        • Lilly C.M.
        • Landry K.E.
        • Sood R.N.
        • Dunnington C.H.
        • Ellison 3rd, R.T.
        • Baley P.H.
        • et al.
        • for the UMass Memorial Critical Care Operations Group
        Prevalence and test characteristics of National Health Safety Network ventilator-associated events.
        Crit Care Med. 2014; ([Epub ahead of print])
        • Klein Klouwenberg P.M.
        • van Mourik M.S.
        • Ong D.S.
        • Horn J.
        • Schultz M.J.
        • Cremer O.L.
        • et al.
        • MARS Consortium
        Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation.
        Am J Respir Crit Care Med. 2014; 189: 947-955
        • Klompas M.
        • Kleinman K.
        • Murphy M.V.
        Descriptive epidemiology and attributable morbidity of ventilator-associated events.
        Infect Control Hosp Epidemiol. 2014; 35: 502-510
        • Boyer A.F.
        • Schoenberg N.
        • Babcock H.
        • McMullen K.M.
        • Micek S.T.
        • Kollef M.H.
        A prospective evaluation of ventilator-associated conditions and infection-related Ventilator-associated conditions.
        Chest. 2014; ([Epub ahead of print])https://doi.org/10.1378/chest.14-0544
        • Muscedere J.
        • Sinuff T.
        • Heyland D.K.
        • Dodek P.M.
        • Keenan S.P.
        • Wood G.
        • et al.
        • Canadian Critical Care Trials Group
        The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated.
        Chest. 2013; 144: 1453-1460
        • Klompas M.
        • Khan Y.
        • Kleinman K.
        • Evans R.S.
        • Lloyd J.F.
        • Stevenson K.
        • et al.
        • CDC Prevention Epicenters Program
        Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation.
        PLoS One. 2011; 6: e18062